Physician Mental Health Has Declined During the Pandemic

WEDNESDAY, Feb. 2, 2022 (HealthDay News) -- The COVID-19 pandemic has been associated with a substantial increase in mental health and substance use visits among physicians, according to a study published online Jan. 21 in JAMA Network Open.
Daniel T. Myran, M.D., M.P.H., from Ottawa Hospital Research Institute in Canada, and colleagues examined the association between the COVID-19 pandemic and changes in outpatient health care visits by physicians related to mental health and substance use. The analysis included health administrative data for 34,055 physicians, residents, and fellows eligible for the Ontario Health Insurance Plan.
The researchers found that the annual crude number of visits per 1,000 physicians increased by 27 percent (816.8 prepandemic to 1,037.5 during the pandemic; adjusted incident rate ratio [IRR] per physician, 1.13). There was an increase in the absolute proportion of physicians with one or more mental health and substance use visits within a year (12.3 percent prepandemic to 13.4 percent during the pandemic; adjusted odds ratio, 1.08). Compared with physicians with a prior mental health and substance use history, the relative increase was significantly greater in physicians without a prior history (adjusted IRR, 1.72).
"Physician mental health may have worsened during the pandemic, highlighting a potential greater requirement for access to mental health services and system level change," the authors write.
One author disclosed financial ties to AstraZeneca.
Related Posts
A muchos padres les preocupa el impacto de las redes sociales en la imagen corporal de sus hijos: encuesta
MARTES, 23 de marzo de 2023 (HealthDay News) -- Alrededor de 7 de cada 10 padres...
Ivermectin Effect in COVID-19 Varies With Strongyloidiasis Prevalence
WEDNESDAY, March 23, 2022 (HealthDay News) -- In trials of ivermectin as a...
J&J le pedirá a la FDA que apruebe la dosis de refuerzo de su vacuna contra la COVID
LUNES, 4 de octubre de 2021 (HealthDay News) -- Johnson & Johnson planifica...
No Increase in Adverse Events Seen With COVID-19 Vaccination After MIS-C
TUESDAY, Jan. 3, 2023 (HealthDay News) -- Patients with a history of multisystem...
